XML 26 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows
$ in Thousands
 12 Months Ended
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Cash flows from operating activities:      
Net income (loss) $ 26,610 $ 31,441 $ (9,555)
Adjustments to reconcile net income to cash flow from operating activities:      
Depreciation and amortization 45,221 34,201 34,824
Amortization of deferred financing costs, net 1,430 1,464 2,757
Stock compensation expense 2,524 1,968 1,222
Net (gains) losses on sale of assets (10,650) (18,825) (31,776)
Net (gains) losses on extinguishment of debt   572 1,210
Change in fair value of derivative instruments (40)    
Acquisition related debt extinguishment expenses   3,624  
(Gains) losses on TSRE merger and property acquisitions     (732)
Changes in assets and liabilities:      
Accounts receivable and other assets (514) (1,267) (477)
Accounts payable and accrued expenses 3,284 1,578 (4,328)
Accrued interest payable 469 (242) (715)
Other liabilities 196 (190) 37
Net cash provided by (used in) operating activities 68,530 54,324 (7,533)
Cash flows from investing activities:      
Acquisition of real estate properties (215,833) (221,813) (1,000)
Disposition of real estate properties 26,802 44,474 39,690
Acquisition of advisory and management contracts     (143)
Capital expenditures (40,426) (14,370) (10,663)
Cash flow provided by (used in) investing activities (229,457) (191,709) 27,884
Cash flows from financing activities:      
Proceeds from issuance of common stock 21,914 137,353 245,309
Payments related to repurchase of common stock     (62,156)
Proceeds from unsecured credit facility and term loan 400,000 199,690 103,501
Credit facility repayments (198,262) (145,685) (345,001)
Proceeds from mortgage     105,980
Mortgage principal repayments (3,191) (2,654) (45,088)
Payments for deferred financing costs (890) (2,089) (1,485)
Distributions on common stock (52,476) (52,304) (36,575)
Distributions to noncontrolling interests (658) (2,119) (2,140)
Payment for interest rate collars (3,730) (2,405)  
Payments related to extinguishment of debt on acquisitions   (3,624)  
Repurchase of shares related to equity award tax withholding (354) (569)  
Net cash provided by (used in) financing activities 162,353 125,594 (37,655)
Net change in cash and cash equivalents, and restricted cash 1,426 (11,791) (17,304)
Cash and cash equivalents, and restricted cash, beginning of period 14,619 26,410 43,714
Cash and cash equivalents, and restricted cash, end of the period 16,045 14,619 26,410
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheet      
Cash and cash equivalents 9,316 9,985 20,892
Restricted cash 6,729 4,634 5,518
Supplemental cash flow information:      
Cash paid for interest 35,532 27,368 33,034
Supplemental disclosure of noncash investing and financing activities:      
Decrease in noncontrolling interest from conversion of common limited partnership units to shares of common stock 14,506 620 2,290
Distributions declared but not paid 16,162 5,245 $ 4,297
Value of limited partnership units issued in acquisitions   1,654  
Mortgage debt assumed 54,756 $ 18,977  
Capital expenditure accrual $ 1,750